DV
Dividend Vision

INSM — Insmed Incorporated

Insmed Incorporated (INSM)

Its deepest 1-year drawdown was 56.5%.

INSM is an individual equity stock rather than an ETF, representing Insmed Incorporated, a biopharmaceutical company focused on respiratory and rare infectious diseases. As a single-stock holding, it does not have the diversification, expense ratio, or regular distribution characteristics typical of dividend ETFs, and it does not pay a dividend yield. This security appeals to investors seeking targeted exposure to a specific biopharmaceutical company's growth potential rather than those pursuing regular dividend income.

INSM key facts

Asset type
Stock
Asset class
Equity
Inception date
02/15/1991
Distribution frequency
None
Last close
$123.74
Market cap
$27,022,526,464
Average volume
1957200.0
Beta
0.793
Payout ratio
0.0
Forward P/E
16.3666
EPS
$-4.12